New Key Statistics Module, Z-Score and F-Score
NAS:SVA Key Ratios
| Market Cap $ M | 460.25 |
| Enterprise Value $ M | -6,772.97 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.07 |
| Price/Sales | 1.76 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 420.00 |
| EPS (TTM) $ | -3.62 |
| Beneish M-Score | 1.29 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 75.40 |
| y-y EBITDA Growth Rate % | -109.40 |
| EV-to-EBIT | 7.03 |
| EV-to-EBITDA | 8.46 |
| PEG | -- |
| Shares Outstanding M | 99.50 |
| Net Margin (%) | -84.05 |
| Operating Margin % | -358.35 |
| Pre-tax Margin (%) | -229.23 |
| Quick Ratio | 9.74 |
| Current Ratio | 9.89 |
| ROA % (ttm) | -2.47 |
| ROE % (ttm) | -3.92 |
| ROIC % (ttm) | -49.59 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.96 |
SVA Number of Guru Trades
SVA Volume of Guru Trades
Gurus Latest Trades with NAS:SVA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SVA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Sinovac Biotech Ltd Insider Transactions
No Available Data
News about NAS:SVA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers